Analyst firms · Needham · BSX
Needham BSX price target and rating history
Boston Scientific Corporation (BSX) · Health Care
Needham rates Boston Scientific Corporation (BSX) Buy with a $113 price target, as of its latest action on Apr 16, 2025. It has published 3 rating actions on BSX since May 2022, including 2 upgrades and 1 downgrade. Across 5 firms with a BSX price target in the last 12 months, the median target is $50.
- Current rating
- Buy
- Price target
- $113
- Median target, all firms
- $50
- Actions on BSX
- 3
Needham price target on BSX
Every Needham rating on BSX
- Apr 16, 2025
- Oct 18, 2024DowngradeNeedham downgrades to Hold from Buy
- May 27, 2022
How other firms rate BSX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| TD Cowen | Hold | $46 | Oct 30, 2026 |
| Oppenheimer | Perform | Oct 29, 2026 | |
| Barclays | Equal Weight | $48 | Oct 7, 2026 |
| Citigroup | Neutral | $50 | Sep 17, 2026 |
| Argus Research | Hold | Jul 31, 2026 | |
| Wolfe Research | Peer Perform | May 29, 2026 | |
| Wells Fargo | Equal Weight | $55 | May 28, 2026 |
| Raymond James | Outperform | $88 | Mar 30, 2026 |
Questions about Needham and BSX
- What is Needham's price target for BSX?
- Needham's latest stated price target for Boston Scientific Corporation (BSX) is $113, from its action on Apr 16, 2025.
- What is Needham's rating on BSX?
- Needham rates BSX Buy, a bullish rating, as of Apr 16, 2025.
- When did Needham last change its view on BSX?
- On Apr 16, 2025, Needham upgrades to Buy from Hold, price target $113.
- How does Needham's BSX target compare with other analysts?
- Across 5 firms with a BSX price target in the last 12 months, the median target is $50.
More BSX rating histories
All Needham ratingsBSX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.